Albert Labs International Corp. (ABRT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | ||
| Accounts receivable | 3 | 149 |
| Other Working Capital | -544 | 965 |
| Other Operating Activity | -892 | -2,026 |
| Operating Cash Flow | $-1,433 | $-912 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -64 | -142 |
| Other Investing Activity | -12 | 0 |
| Investing Cash Flow | $-76 | $-142 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1,511 | 1,116 |
| Financing Cash Flow | $1,511 | $1,116 |
| Beginning Cash Position | 77 | 11 |
| End Cash Position | 79 | 73 |
| Net Cash Flow | $2 | $62 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,433 | -912 |
| Capital Expenditure | -64 | -142 |
| Free Cash Flow | -1,497 | -1,054 |